CHRONIC LYMPHOID LEUKEMIA
Clinical trials for CHRONIC LYMPHOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOID LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial tests new drug combos to improve CLL outcomes
Disease control OngoingThis study compares three treatment approaches for people with previously untreated chronic lymphocytic leukemia (CLL): continuous ibrutinib alone, a fixed-duration combination of venetoclax plus obinutuzumab, and a fixed-duration combination of ibrutinib plus venetoclax. The mai…
Matched conditions: CHRONIC LYMPHOID LEUKEMIA
Phase: PHASE3 • Sponsor: German CLL Study Group • Aim: Disease control
Last updated May 26, 2026 11:24 UTC
-
New drug targets high-risk leukemia before symptoms worsen
Disease control OngoingThis study tests whether the drug venetoclax can help people with early-stage, high-risk chronic lymphocytic leukemia (CLL). About 82 participants with specific risk factors will receive venetoclax to see if it can reduce cancer cells to very low levels in the bone marrow after 1…
Matched conditions: CHRONIC LYMPHOID LEUKEMIA
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated May 19, 2026 11:48 UTC